CNBX Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -176.9% | -176.9% | -103.8% |
| FY2022 | -228.1% | -228.1% | -459.0% |
| FY2023 | 183.9% | 183.9% | -743.5% |
| FY2024 | 28.0% | 28.0% | -2,215.2% |
| FY2025 | 12.6% | 12.6% | -1,703.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -176.9% | -176.9% | -103.8% |
| FY2022 | -228.1% | -228.1% | -459.0% |
| FY2023 | 183.9% | 183.9% | -743.5% |
| FY2024 | 28.0% | 28.0% | -2,215.2% |
| FY2025 | 12.6% | 12.6% | -1,703.0% |